Shanghai, China

Yongmei Xu

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
3 patents (USPTO):

Title: Yongmei Xu: Innovator in Gastric Acid-Related Treatments

Introduction

Yongmei Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the development of treatments for gastric acid-related diseases. With a total of 3 patents, his work has garnered attention in the pharmaceutical industry.

Latest Patents

Yongmei Xu's latest patents include innovative compounds aimed at addressing gastric acid-related conditions. One of his notable inventions is a class of substituted pyrrolo[3,4-c]pyrazoles for treating gastric acid-related diseases. This invention is represented by a specific formula, showcasing its potential therapeutic applications. Another significant patent involves pyrrolopyrazole derivatives, which includes a preparation method and application in medicine. These derivatives serve as gastric acid secretion inhibitors and potassium-competitive acid blockers (P-CABs), highlighting their importance in biomedicine.

Career Highlights

Throughout his career, Yongmei Xu has worked with reputable organizations, including Shanghai Medicilon Inc. and Medicilon Preclinical Research (Shanghai) LLC. His experience in these companies has allowed him to advance his research and contribute to the development of effective medical treatments.

Collaborations

Yongmei Xu has collaborated with several professionals in his field, including Feng Ren and Xianlian Wang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing his innovative work.

Conclusion

Yongmei Xu's contributions to the field of medicine, particularly in the treatment of gastric acid-related diseases, demonstrate his commitment to innovation. His patents and collaborations reflect a dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…